Literature DB >> 1921242

Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L.).

J L Schultze1, A Stettin, P A Berg.   

Abstract

Lymphocytes of 25 patients treated with an aqueous mistletoe extract (Viscum album L.) for up to 6 months (group 1), up to 2 years (group 2), and more than 2 years (group 3) were examined in 3- and 7-day cultures for specifically sensitized lymphocytes. The whole extract (HM), the lectin-polysaccharide fraction (HM-LP), and the 'viscotoxin' fraction (HM-V) were added at concentrations ranging from 0.5 micrograms to 12.5 mg extract/ml. Lymphocytes from four of the nine group 2 patients and five of the ten group 3 patients reacted specifically with HM and HM-LP at an optimal dose of 5.0 mg/ml, but did not react with HM-V. Stimulation indices varied between 1.6 and 16. In the patients of group 3 this effect was observed only when their lymphocytes were co-stimulated in the 3-day cultures with phytohemagglutinin (PHA), in contrast to the four patients of group 2 who reacted only in the 7-day cultures with HM-LP without PHA co-stimulation. Patients' lymphocytes had to be protected from mistletoe lectin-induced cytotoxicity by the addition of their own sera containing anti-mistletoe lectin antibodies. Lymphocytes from tumor patients (n = 18) never treated with mistletoe extracts and healthy individuals (n = 18) showed no specific proliferative response when tested in 3- and 7-day cultures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921242     DOI: 10.1007/bf01647413

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.

Authors:  A Stettin; J L Schultze; E Stechemesser; P A Berg
Journal:  Klin Wochenschr       Date:  1990-09-14

2.  Two types of mouse helper T-cell clone Implications for immune regulation.

Authors:  T R Mosmann; R L Coffman
Journal:  Immunol Today       Date:  1987

3.  Effects of lectin I from mistletoe (ML I) and its isolated A and B chains on human mononuclear cells: mitogenic activity and lymphokine release.

Authors:  G Metzner; H Franz; A Kindt; I Schumann; B Fahlbusch
Journal:  Pharmazie       Date:  1987-05       Impact factor: 1.267

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  [Ingredients of mistletoe (Viscum album L.) as potential drugs].

Authors:  H Franz
Journal:  Pharmazie       Date:  1985-02       Impact factor: 1.267

6.  The lectin from Viscum album L.--isolation, characterization, properties and structure.

Authors:  P Luther; H Theise; B Chatterjee; D Karduck; G Uhlenbruck
Journal:  Int J Biochem       Date:  1980

7.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Mediation of human NK-activity by components in extracts of Viscum album.

Authors:  K Hamprecht; R Handgretinger; W Voetsch; F A Anderer
Journal:  Int J Immunopharmacol       Date:  1987

9.  Influence of carbohydrates on the cytotoxicity of an aqueous mistletoe drug and of purified mistletoe lectins tested on human T-leukemia cells.

Authors:  C Doser; M Doser; H Hülsen; F Mechelke
Journal:  Arzneimittelforschung       Date:  1989-06

10.  Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.

Authors:  T Hajto; K Hostanska; H J Gabius
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

View more
  5 in total

1.  Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.

Authors:  G Stein; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

2.  The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes.

Authors:  F W Busch; A Tillmann; E W Becker; M Owsianowski; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Synergistic anticancer effects of lectin and doxorubicin in breast cancer cells.

Authors:  Chang-Eui Hong; Ae-Kyung Park; Su-Yun Lyu
Journal:  Mol Cell Biochem       Date:  2014-05-31       Impact factor: 3.396

Review 4.  Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.

Authors:  Gul-E-Saba Chaudhry; Abdah Md Akim; Yeong Yik Sung; Tengku Muhammad Tengku Sifzizul
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

5.  Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.

Authors:  M Mabed; L El-Helw; S Shamaa
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.